FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

158511000001109: Cefalexin 250mg/5ml oral suspension (Unichem Plc) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16153101000001112 Cefalexin 250mg/5ml oral suspension (Unichem Plc) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
54446601000001113 Cefalexin 250mg/5ml oral suspension (Alliance Healthcare (Distribution) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cefalexin 250mg/5ml oral suspension (Unichem Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cefalexin 250mg/5ml oral suspension (Unichem Plc) Is a Product containing precisely cefalexin 50 milligram/1 milliliter conventional release oral suspension true Inferred relationship Existential restriction modifier
Cefalexin 250mg/5ml oral suspension (Unichem Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Cefalexin 250mg/5ml oral suspension (Unichem Plc) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Cefalexin 250mg/5ml oral suspension (Unichem Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cefalexin 250mg/5ml oral suspension (Unichem Plc) Has active ingredient Bactericide false Inferred relationship Existential restriction modifier
Cefalexin 250mg/5ml oral suspension (Unichem Plc) Has active ingredient Cefalexin false Inferred relationship Existential restriction modifier
Cefalexin 250mg/5ml oral suspension (Unichem Plc) Has active ingredient Substance with antibacterial mechanism of action false Inferred relationship Existential restriction modifier
Cefalexin 250mg/5ml oral suspension (Unichem Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cefalexin 250mg/5ml oral suspension (Unichem Plc) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Cefalexin 250mg/5ml oral suspension (Unichem Plc) Has manufactured dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Cefalexin 250mg/5ml oral suspension (Unichem Plc) Has specific active ingredient Cefalexin true Inferred relationship Existential restriction modifier
Cefalexin 250mg/5ml oral suspension (Unichem Plc) Has active ingredient Cefalexin monohydrate false Inferred relationship Existential restriction modifier
Cefalexin 250mg/5ml oral suspension (Unichem Plc) Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Cefalexin 250mg/5ml oral suspension (Unichem Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Cefalexin 250mg/5ml oral suspension (Unichem Plc) 100 ml Is pack of False Cefalexin 250mg/5ml oral suspension (Unichem Plc) Inferred relationship Existential restriction modifier
Cefalexin 250mg/5ml oral suspension (Unichem Plc) 100 ml Has AMP True Cefalexin 250mg/5ml oral suspension (Unichem Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start